ASCO Genitourinary Cancers Symposium


 

ASCO GU 2022: An AI-Derived Digital Pathology-Based Biomarker to Predict the Benefit of ADT in Localized Prostate Cancer With Validation in NRG/RTOG 9408

43 views
March 14, 2022
0 Comments
Login to view comments. Click here to Login